title: Mesenchymal stem cell therapy in acute lung injury: is it time for a clinical trial?
authors.forename: Rob
authors.initials: R
authors.lastname: Mac Sweeney
authors.forename: Daniel Francis
authors.initials: DF
authors.lastname: McAuley
mesh_terms: D000209:Acute-Phase Proteins / Q000378:metabolism*; D000818:Animals; D004926:Escherichia coli / Q000472:pathogenicity*; D004927:Escherichia coli Infections / Q000150:complications* / Q000601:surgery*; D016753:Interleukin-10 / Q000096:biosynthesis*; D000071068:Lipocalin-2; D054834:Lipocalins / Q000378:metabolism*; D008297:Male; D045164:Mesenchymal Stem Cell Transplantation; D015513:Oncogene Proteins / Q000378:metabolism*; D018410:Pneumonia, Bacterial / Q000382:microbiology*; D014409:Tumor Necrosis Factor-alpha / Q000187:drug effects*; D055397:Ventilator-Induced Lung Injury / Q000601:surgery*
chemical_list: D000209:Acute-Phase Proteins; D000071068:Lipocalin-2; D054834:Lipocalins; D015513:Oncogene Proteins; D014409:Tumor Necrosis Factor-alpha; C071332:Lcn2 protein, mouse; D016753:Interleukin-10